Clinical Trial Update: CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing CyBorD with PAD for newly diagnosed multiple myeloma. The regimens consist of cyclophosphamide, bortezomib, and dexame…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN